The endocannabinoid system (ECS) is a biological system composed of endocannabinoids, The localization of the CB1 receptor in the endocannabinoid system has a very large degree of overlap with the explain why cannabinoids possess a greater efficacy in altering rodent motor movements than they do in humans. Here's why: we (as in, humans, and many animals) have cannabinoid receptors and an endocannabinoid system that processes cannabinoids. All these systems make up the human body. But did you know you also have an endocannabinoid system (ECS)? You probably didn't because.
endocannabinoid We an actually system. have
And disrupted endocannabinoid signaling has been associated with many disorders, including diabetes, hypertension, infertility, liver disease, and more. Now an assistant professor at University of California, Riverside, School of Medicine, DiPatrizio has trained his whole research program on the gut, where the endocannabinoid system appears to be a major player in human health and disease.
In January, his lab suggested that endocannabinoid signaling in the gut drives the overeating characteristic of Western diets. In a rodent model, chronic consumption of a high-fat and high-sugar diet led to elevated levels of endocannabinoids in the gut and blood, promoting further consumption of fatty foods.
Blocking endocannabinoids from their receptors decreased overeating in the animals, his team found. Because of that link to appetite, pharmaceutical companies have sought to target the endocannabinoid system to create the ultimate diet pill, a drug to reduce appetite or treat metabolic disorders.
Those efforts have recently been subdued by two tragic and highly visible failures. But some scientists still hope that by understanding the true nature of this system, they might identify new treatments, especially for conditions related to gut health and metabolism. And that realization came from an unusual source—an oft-derided effort to understand how marijuana gets us high.
More than two decades later, in , investigators found the first direct evidence of an endogenous signaling system for THC—a receptor in the rat brain that bound a synthetic version of THC with high affinity.
The receptor, called CB 1 , was subsequently identified in other mammalian brains, including those of humans, and appeared to be present in similar density to receptors for other neurotransmitters, including glutamate, GABA, and dopamine.
That surprising finding was an omen of things to come; the endocannabinoid system functions far afield from the brain, practically everywhere in the body. The presence of these receptors sparked a quest to find natural ligands that bind to them. Maccarrone suspects that endocannabinoids are among the oldest signaling molecules to be used by eukaryotic cells. His team recently showed that anandamide and its related enzymes are present in truffles, delectable fungi that first arrived on the evolutionary scene about million years ago, suggesting endocannabinoids evolved even earlier than cannabis plants.
In the brain, endocannabinoids interact with other neurotransmitters; in the reproductive tract, with steroid hormones; in the muscles, with myokines; and so on. In healthy, nonobese animals, there is typically no consequence to knocking out endocannabinoid receptors in peripheral organs. The idea that cannabis—or, by extension, endogenous cannabinoids—affects the gut is not surprising. Preparations derived from marijuana plants have long been used to treat digestive conditions such as inflammatory bowel disease and vomiting.
Even before CB 1 was discovered, scientists had suggested that cannabinoids regulate the motility of the gastrointestinal tract—the orchestrated movements of muscles that churn and move food through the intestines. For example, in , Australian researchers showed that oral ingestion of THC slowed the passage of a meal through the intestines of mice.
These pathways are conserved among many species. Both CB 1 and CB 2 receptors are present and active in the gut, though they appear to be involved in different gut functions. At the University of Calgary, Keith Sharkey and colleagues found that increased intestinal motility in the inflamed gut was reversed when CB 2 receptors, but not CB 1 receptors, were activated. We are now at a point where you have to understand how endocannabinoids can be so relevant in so many areas—literally everywhere in the body.
To make things even more complicated, there is a group of nonclassical receptors that interact with endocannabinoids in the gut, says Jakub Fichna , head of the department of biochemistry at the Medical University of Lodz in Poland. For example, if you have inflammation, most of the time you have decreasing pH, and this is already enough for some of the endocannabinoid receptors to be activated.
Endocannabinoids and their receptors also appear to be involved in gastric secretions, ion transport, and cell proliferation in the gut. And then there is appetite. Kunos wondered whether endocannabinoids cause a similar increase in appetite. In , with the help of collaborators, he confirmed the suspicion: Additional research has supported that idea that endocannabinoids act as a general appetite-promoting signal. During his postdoc, DiPatrizio found that when rodents tasted dietary fats just tasted, not swallowed , endocannabinoid levels increased in the rat small intestine—and nowhere else in the body.
A CB 1 receptor antagonist blocked that signal, leading the rodents to decrease their ingestion of fatty foods. From an evolutionary perspective, having a positive feedback mechanism for fat intake makes sense, he adds. When an animal in the wild detects high-energy foods, it is beneficial to stock up. Sharkey sees the system as a regulator of homeostasis within the body, especially considering its roles in maintenance of food intake, body weight, and inflammation.
In obesity, both CB 1 and CB 2 receptors are upregulated throughout the body, including in the liver and in adipose tissue. And the activation of CB 1 receptors increases food intake and affects energy metabolism in peripheral tissues.
In type 2 diabetes, endocannabinoids and their receptors are upregulated in circulating macrophages and contribute to the loss of pancreatic beta cells, which store and release insulin. Interestingly, chronic marijuana users have no documented increased incidence of diabetes or obesity. Researchers speculate this is because chronic use results in downregulation of CB 1 receptors—a form of pharmacological tolerance. And whether they be small stressors like getting stuck in traffic, or large sources of stress like losing a loved one, we encounter stress in one form or another on a daily basis.
Fascinating research has identified that the endocannabinoid system plays a major role in the way our body responds to stress. In the future, we may be able to leverage this knowledge to cope with chronic stress and minimize its negative consequences. This could have major implications for how we diagnose and treat illnesses.
Almost every health problem out there—including extremely common ones like depression, heart disease, GI issues, asthma, and headaches—can be exacerbated by stress and are likely even caused by it.
Understanding how our "master regulatory system" works, and how cannabinoids influence this system, might just be the key to taming stress and taking control of our health.
Are you going to the biggest wellness event of the year? We'll be talking all about cannabinoids, hemp, and the ECS. Food has the power to create a happier and healthier world. Celebrity Nutritionist Kelly LeVeque will show you how. Integrative Health integrative health. Group 8 Created with Sketch. By Gretchen Lidicker mbg Health Editor.
June 15, — Group 7 Created with Sketch. Group 9 Created with Sketch. Group 10 Created with Sketch. Group 11 Created with Sketch. Email Created with Sketch. Group 4 Created with Sketch. Here's what I mean: Understanding marijuana, hemp, and CBD. Getting to know all the different kinds of cannabinoids. What we know and what we suspect.
The future of the endocannabinoid system. Gretchen Lidicker mbg Health Editor. Originally from Sedona, Arizona, she has a Caroline Muggia 10 hours ago.
In the past decade, the endocannabinoid system has been implicated in a growing Here, we provide a comprehensive overview on the current state of were found to actually reduce infarct size and to improve neurological function in a. But even though researchers have documented the existence of the endocannabinoid system throughout the body, they still don't really know. The endocannabinoid system plays many crucial roles in your body, and So when you're really hot and begin to sweat, thank your ECS for working to cool you down. We have (at least) two types of cannabinoid receptors.